Genomic & Biopharma NewsMedical device industry 'not doing enough on cybersecurity'
The medical device industry appears to be under siege by cybercriminals, but it isn't taking steps to defend itself, according to two separate reports.
|Fierce Biotech, 2017-05-26 10:36:28|
Preventing newborn baby deaths in ambulances with new stretcher
Academics and industry partners in Birmingham are developing a new device that will ensure newborn babies could survive in the event of a crash in an ambulance at up to 40 miles per hour.
|News Medical Life Sciences, 2017-05-26 10:14:32|
UK Lebanon Tech Hub to fund research and development of non-invasive blood glucose-monitoring device
UK Lebanon Tech Hub announced today that it will fund the research and development of ediamond (Electromagnetic Diabetes Monitoring Device): a one of its kind non-invasive blood glucose-monitoring device, which is being developed by the Maroun Semaan faculty of Engineering and Architecture and the Faculty of Medicine at the American University of Beirut.
|News Medical Life Sciences, 2017-05-26 10:07:24|
Attendance of UK MedTech companies highest recorded at CMEF
The largest delegation of UK healthcare companies took part in this year’s China Medical Equipment Fair (CMEF); waving the British flag for innovation in China.
|News Medical Life Sciences, 2017-05-26 10:02:12|
Philips sponsors research to help COPD patients breathe easier
Recently published advancements in pulmonary research suggest that the combination of non-invasive ventilation (NIV) and home oxygen therapy (HOT) can significantly prolong time to readmission or death for patients with chronic obstructive pulmonary disease (COPD) following a life-threatening respiratory event or exacerbation. The five-year, multi-center study resulted in prolonged median time to readmission or death by nearly three months, and improved patient health-related quality of life in the first six weeks.
|News Medical Life Sciences, 2017-05-26 10:02:05|
Clinical study tests 100-year-old drug in children with autism spectrum disorder
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
|News Medical Life Sciences, 2017-05-26 09:55:45|
Gottlieb ends FDA hiring freeze, lays out R&D priorities
Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA. The action means Gottlieb can fill vacancies to shape an agency capable of enacting his plans for how safety and efficacy information are gathered during development.
|Fierce Biotech, 2017-05-26 09:36:34|
Priority review for BMS’ Opdivo in liver cancer
US regulators will undertake a speedy review of Bristol-Myers Squibb’s application to expand use of its immunotherapy Opdivo to include to include certain patients with liver cancer.
|PharmaTimes, 2017-05-26 09:04:58|
Pfizer’s Epogen/Procrit biosimilar wins US backing
Pfizer’s biosimilar of Amgen’s epoetin alfa (Epogen/Procrit) has won backing in the US for approval across all proposed indications.
|PharmaTimes, 2017-05-26 09:01:59|